Non-signaling decoy receptors (e.g. the FasL-mimicking decoy receptors DcR 1-3) and soluble decoy proteins (such as osteoprotegerin) are over-expressed in many tumor types and can further impede death-receptor signaling (159). This evidence concerns the gene FASLG and neoplasm.